Written Question·Department of Health and Social Care·UIN 97926
Vorasidenib
Tabled: 8 December 2025
Answered: 15 December 2025
Question
Wendy Chamberlain
Liberal Democrat — North East Fife
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of the use of the drug Vorasidenib to manage the symptoms and progression of low grade Glioma.
Answer
Dr Zubir AhmedWhile the Department has made no assessment, the National Institute for Health and Care Excellence (NICE) is the independent body that makes evidence-based recommendations for the National Health Service on whether new medicines should be routinely funded...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 97926) →